Research & Publications
Dr. Nowak is focused on elucidating the immunopathologic mechanisms of myasthenia gravis, an autoimmune disorder targeting the neuromuscular junction in patients resulting in weakness. He is working toward identifying new drug targets as well as exploring the effectiveness of B cell directed therapies (e.g., rituximab).
Specialized Terms: Myasthenia Gravis; Guillian-Barre Syndrome (GBS); CIDP; Immune Therapies, Neuropathy; Charcot Marie Tooth Disease; ALS.
Extensive Research Description
Amyotrophic Lateral Sclerosis; Charcot-Marie-Tooth Disease; Myasthenia Gravis; Neurology; Guillain-Barre Syndrome; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating